Table 2 Description of initial antibiotic therapy for 549 inpatients
Initial therapy | Total n = 549 | CAP n = 295 | ICP n = 125 | HCAP n = 129 |
|---|---|---|---|---|
Monotherapy | 305 (55.6) | 156 (52.9) | 64 (51.2) | 85 (65.9) |
Amoxicillin-clavulanate | 108 (35.4) | 56 (35.9) | 14 (21.9) | 38 (44.7) |
Levofloxacin | 129 (42.3) | 76 (48.7) | 24 (37.5) | 29 (34.1) |
Ceftriaxone | 22 (7.2) | 13 (8.3) | 7 (10.9) | 2 (2.4) |
β-APS | 45 (14.8) | 11 (7.1) | 18 (28.1) | 16 (18.8) |
Piperacillin-tazobactam | 26 (8.5) | 3 (1.9) | 12 (18.8) | 11 (12.9) |
Cefepime | 3 (1.0) | 2 (1.3) | 1 (1.6) | 0 (0.0) |
Meropenem | 16 (5.2) | 6 (3.8) | 5 (7.8) | 5 (5.9) |
Others | 1 (0.3) | |||
Combination | 244 (44.4) | 139 (47.1) | 61 (48.8) | 44 (34.1) |
Ceftriaxone + macrolide | 190 (77.9) | 119 (85.6) | 41 (67.2) | 30 (68.2) |
β-APS + quinolone or aminoglycoside or macrolide | 33 (13.5) | 9 (6.5) | 15 (24.6) | 9 (20.5) |
Others | 21 (8.6) | 11 (7.9) | 5 (8.2) | 5 (11.4) |